Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Using a bedside test to detect genetic susceptibility to aminoglycoside-induced hearing loss: Has the future arrived?

Journal of paediatrics and child health - 1 Jan 2023

May Meryta L, Osowicki Joshua, Gaafar Duaa, Suthers Graeme

Abstract excerpt

Aminoglycosides are among the most commonly prescribed antibiotics in hospitalised Australian adults and children. A proportion of individuals with an underlying genetic predisposition to aminoglycoside-induced hearing loss (AIHL) can develop bilateral sensorineural hearing loss that is immediate and profound after just a single standard dose of an aminoglycoside. A recent publication described the use of a rapid...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aminoglycosides
Share to Anti-Bacterial Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Australia

Share to Hearing Loss

Share to Hearing Loss, Sensorineural

Share to Infant

Share to Infant, Newborn

Source

Open in PubMed Open full text

Identifiers

PMID: 36465032
DOI: 10.1111/jpc.16302
PMCID: PMC10107546

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Using a bedside test to detect genetic susceptibility to aminoglycoside-induced hearing loss: Has the future arrived?PMID 36465032Read ↗

Genetic testing in the acute setting: a round table discussion.Semantic proximity Read ↗

Rapid Point-of-Care Genotyping to Avoid Aminoglycoside-Induced Ototoxicity in Neonatal Intensive Care.Semantic proximity Read ↗

Non-invasive Prenatal MT-RNR1 Pharmacogenetic Testing for the Prevention of Aminoglycoside-Induced Profound Hearing LossSemantic proximity Read ↗

Clinical Pharmacogenetics Implementation Consortium Guideline for the Use of Aminoglycosides Based on MT-RNR1 Genotype.Semantic proximity Read ↗

A cohort study of neonatal hearing testing and genetic screening for variants associated with susceptibility to aminoglycoside antibiotic-induced hearing loss in Beijing, China.Semantic proximity Read ↗

Clinical Pharmacogenomic MT-RNR1 Screening for Aminoglycoside-Induced Ototoxicity and the Post-Test Counseling Conundrum.Semantic proximity Read ↗

[Pharmacogenetics of aminoglycoside ototoxicity: State of knowledge and practices - Recommendations of the Francophone Network of Pharmacogenetics (RNPGx)].Semantic proximity Read ↗

Genedrive kit for detecting single nucleotide polymorphism m.1555A>G in neonates and their mothers: a systematic review and cost-effectiveness analysis.Semantic proximity Read ↗

Aminoglycoside toxicity in neonates: something to worry about?Semantic proximity Read ↗

Detecting mitochondrial mutations associated with aminoglycoside ototoxicity by noninvasive prenatal testing.Semantic proximity Read ↗

The future role of genetic screening to detect newborns at risk of childhood-onset hearing loss.Semantic proximity Read ↗

Genetic susceptibility to aminoglycoside ototoxicity: how many are at risk?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.